ClinicalTrials.Veeva

Menu

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China (ChiTwiMC)

P

Peking University

Status

Enrolling

Conditions

Pre-Eclampsia
Twin Monochorionic Diamniotic Placenta
Twin to Twin Transfusion as Antepartum Condition
High Risk Pregnancy
Pre-Term
Twin Pregnancy, Antepartum Condition or Complication
Twin Placenta
Twin Dichorionic Diamniotic Placenta

Study type

Observational

Funder types

Other

Identifiers

NCT06414655
ChiTwiMC

Details and patient eligibility

About

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China (ChiTwiMC) is supported by National Key Research and Development Program of China - Reproductive Health and Women's and Children's Health Protection Project. This project is funded by the Ministry of Science and Technology of China under grant number 2023YFC2705900. The ChiTwiMC cohort is led by Professor Wei Yuan from the Department of Gynecology and Obstetrics at Peking University Third Hospital.

Full description

The ChiTwiMC Cohort focusing on the serious complications of twin pregnancy, establish a multicenter large prospective mother-child cohort of twin pregnancy covering pregnancy→neonatal period→early childhood, and a multi-variety, multi-stage biobank for the study of adverse outcomes of twin pregnancy. The ChiTwiMC Cohort is planning to recruit 2000 pregnant women aged 18-45 years from 9 large obstetrical center of major University-affiliated Hospitals across China, between December 2023 and May 2026. All women will be enrolled prior to 14 wks of gestation, pregnancy was followed up at 22-28 wks, 30-38 wks of gestation, delivery, postpartum 42 days, 6 months, 12 months. Data including demographics, medical history, reproductive history, clinical diagnosis, treatment information, and pregnancy and birth outcomes will be collected via electronic data capture system. Track the outcome of severe maternal-fetal complications and early neonatal outcomes of twins, and collect biological samples, including peripheral venous blood, hair and cervicovaginal secretions from pregnant women, placenta tissue, amniotic fluid and unbilical cord blood at delivery, meconium and hair from newborns, buccal mucosa from infants and peripheral venous blood from the husband.

Enrollment

2,000 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Twin pregnancies
  • Female aged between 18-45 years
  • Gestational age is less than 14 weeks
  • Planning to receive prenatal healthcare and delivery service at the study hospital
  • Signing informed concent and willing to participate

Exclusion criteria

  • Women with mental disorders or serious maternal illness that is not eligible to participate
  • Inability to provide informed consent
  • Pregnant women not registered in our hospital

Trial contacts and locations

11

Loading...

Central trial contact

Tianchen Wu, PhD; Yuan Wei, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems